(Q38034735)

27 August 2017

title

Implication of cancer stem cells in cancer drug development and drug delivery (English)

1 reference

27 August 2017

1 reference

neoplastic stem cells

1 reference

Edward Kai-Hua Chow

1

0 references

publication date

14 August 2012

1 reference

Journal of Laboratory Automation

27 August 2017

published in

1 reference

27 August 2017

volume

18

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

6-11

1 reference

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Cancer stem cells in solid tumors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Cancer stem cells in human gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

The evolution of signalling pathways in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Medulloblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Active nanodiamond hydrogels for chemotherapeutic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Polymer-functionalized nanodiamond platforms as vehicles for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Gd(III)-nanodiamond conjugates for MRI contrast enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Drug delivery with carbon nanotubes for in vivo cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Liposomes modified with cyclic RGD peptide for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Phenotypic characterization of human colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

Molecular mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2211068212454739

21 January 2018

Identifiers

DOI

10.1177/2211068212454739

1 reference

27 August 2017

1 reference